TY - JOUR
T1 - A case of acute exacerbation of idiopathic pulmonary fibrosis after proton beam therapy for non-small cell lung cancer
AU - Nagano, Tatsuya
AU - Kotani, Yoshikazu
AU - Fujii, Osamu
AU - Demizu, Yusuke
AU - Niwa, Yasue
AU - Ohno, Yoshiharu
AU - Nishio, Wataru
AU - Itoh, Tomoo
AU - Murakami, Masao
AU - Nishimura, Yoshihiro
PY - 2012/10
Y1 - 2012/10
N2 - There have been no reports describing acute exacerbations of idiopathic pulmonary fibrosis after particle radiotherapy for non-small cell lung cancer. The present study describes the case of a 76-year-old Japanese man with squamous cell carcinoma of the lung that relapsed in the left upper lobe 1 year after right upper lobectomy. He had been treated with oral prednisolone 20 mg/day every 2 days for idiopathic pulmonary fibrosis, and the relapsed lung cancer was treated by proton beam therapy, which was expected to cause the least adverse effects on the idiopathic pulmonary fibrosis. Fifteen days after the initiation of proton beam therapy, the idiopathic pulmonary fibrosis exacerbated, centered on the left upper lobe, for which intensive steroid therapy was given. About 3 months later, the acute exacerbation of idiopathic pulmonary fibrosis had improved, and the relapsed lung cancer became undetectable. Clinicians should be aware that an acute exacerbation of idiopathic pulmonary fibrosis may occur even in proton beam therapy, although proton beam therapy appears to be an effective treatment option for patients with idiopathic pulmonary fibrosis.
AB - There have been no reports describing acute exacerbations of idiopathic pulmonary fibrosis after particle radiotherapy for non-small cell lung cancer. The present study describes the case of a 76-year-old Japanese man with squamous cell carcinoma of the lung that relapsed in the left upper lobe 1 year after right upper lobectomy. He had been treated with oral prednisolone 20 mg/day every 2 days for idiopathic pulmonary fibrosis, and the relapsed lung cancer was treated by proton beam therapy, which was expected to cause the least adverse effects on the idiopathic pulmonary fibrosis. Fifteen days after the initiation of proton beam therapy, the idiopathic pulmonary fibrosis exacerbated, centered on the left upper lobe, for which intensive steroid therapy was given. About 3 months later, the acute exacerbation of idiopathic pulmonary fibrosis had improved, and the relapsed lung cancer became undetectable. Clinicians should be aware that an acute exacerbation of idiopathic pulmonary fibrosis may occur even in proton beam therapy, although proton beam therapy appears to be an effective treatment option for patients with idiopathic pulmonary fibrosis.
UR - http://www.scopus.com/inward/record.url?scp=84866769968&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84866769968&partnerID=8YFLogxK
U2 - 10.1093/jjco/hys115
DO - 10.1093/jjco/hys115
M3 - Article
C2 - 22826350
AN - SCOPUS:84866769968
SN - 0368-2811
VL - 42
SP - 965
EP - 969
JO - Japanese journal of clinical oncology
JF - Japanese journal of clinical oncology
IS - 10
M1 - hys115
ER -